Andrew Callos Cytokinetics Inc (CYTK) insider trading activity

Andrew Callos is EVP, Chief Commercial Officer of CYTOKINETICS INC. Currently has a direct ownership of 63,887 shares of CYTK, which is worth approximately $3.55 Million. The most recent transaction as insider was on Mar 14, 2024, when has been sold 16,941 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.9K

0% 3M change

19.01% 12M change

Total Value Held $3.55 Million

Andrew Callos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2024	BUY Grant, award, or other acquisition	-	16,941 Added 20.96%	63,887 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$341,288 $66.88 p/Share	5,103 Reduced 9.8%	46,946 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$149,031 $67.68 p/Share	2,202 Reduced 4.06%	52,049 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	30,000 Added 35.85%	53,683 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$87,199 $39.6 p/Share	2,202 Reduced 8.51%	23,683 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$42,761 $44.13 p/Share	969 Reduced 3.61%	25,885 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	20,000 Added 43.29%	26,196 Common Stock

Feb 16 2022	BUY Grant, award, or other acquisition	-	5,044 Added 44.88%	6,196 Common Stock

Andrew Callos

EVP, Chief Commercial Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account